Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Nebius Group NV (NBIS) Price & Performance

Amylx Pharmaceuticals IncTrade
Nebius Group NVTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Nebius Group NV — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Nebius Group NV trades at $218 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 18.6× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.

AMLXNBIS
Market Cap
$2.64B$49.06B
Sector
HealthTechnology
52-Week High
$24.19$286.69
52-Week Low
$7.82$64.06
Enterprise Value
$2.39B$49.26B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Nebius Group NV

Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.

Read more on NBIS